Sun Pharma may discontinue some non-strategic businessesDilip Shanghvi said the company expects to incur certain integration charges in order to generate long-term synergies from the merger (with...
FDA concern leading to worry on Indian pharma: Sonam Udasi, IDBI CapitalSonam Udasi, Head of Research, IDBI Capital, shares his view on the Pharma sector.
Dealing room buzz: Sun Pharma, RInfra, Ranbaxy and BhartiET Now spoke to dealers on institutional and HNI's activity in the dealing room. These stocks were on their radar on unconfirmed reports.
Glenmark gets USFDA nod for generic Desoximetasone ointmentThe Desoximetasone Ointment USP is the generic version of Taro Pharmaceuticals USA Inc's Topicort and shipping will commence immediately, G...
Sun Pharma hits fresh record high, market cap exceeds Rs 1 lakh croreM-cap of Sun Pharma exceeded Rs 1 lakh cr and exceeds total value of DRL, Lupin & Cipla. Sun Pharma is now the 14th most valuable co.